Tata India Pharma & Healthcare Fund - Direct (G)

Fund Class : Equity - Pharma
Fund House : Tata Mutual Fund
Aum(Rs Cr) : 73.67
NAV 21 Nov 2017 8.88 0.13
(1.49%)

NAV High-Low (in Rs)

ONE Mth 107.50
107.50
52-WEEk 73.06
107.50

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 1.5 0.85 - - -
Sensex 2.43 3.61 9.77 29.26 18.43
Nifty 2.21 1.92 9.57 29.23 21.99

Fund Features

Types of Scheme Growth
Options Equity
Assets Size (Rs in Cr) 73.67 (31 Jan 16)
Inception Date 04 Dec 15
Fund Manager Sonam Udasi

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 31 Oct 2017
Category Share (%)
Equity 94.90
Reverse Repo 5.09
› More
   As On 31 Oct 2017
Sector Name Amount
Healthcare 9.30
NA 5.09
Pharmaceuticals - Indian - Bulk Drugs 9.93
Pharmaceuticals - Indian - Bulk Drugs & Formln 70.41
Pharmaceuticals - Multinational 5.26
› More
   As On 31 Oct 2017
Company Name
Sun Pharma.Inds. 21.52
Aurobindo Pharma 8.64
Divi's Lab. 8.03
Piramal Enterp. 7.44
Cadila Health. 7.01
Ipca Labs. 5.45
Dishman Carbogen 4.70
Alembic Pharma 4.50
› More

Fund DETAILS

Asset Management Co.

Registered Address

Tata Asset Management Ltd,

Mafatlal Centre9th Floor
Nariman Point
Mumbai - 400 021.

Phone: 022 - 6657 8282. | Fax: 022 - 2261 3782.

Email: kiran@tataamc.com

Website: www.tatamutualfund.com